Chongqing Lummy Pharmaceutical Co., Ltd. (SHE:300006)

China flag China · Delayed Price · Currency is CNY
6.53
+0.14 (2.19%)
May 6, 2026, 3:07 PM CST
Market Cap6.90B +81.9%
Revenue (ttm)759.50M -6.6%
Net Income-135.94M
EPS-0.13
Shares Out1.06B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume40,006,603
Average Volume78,816,222
Open6.39
Previous Close6.39
Day's Range6.16 - 6.59
52-Week Range3.31 - 6.67
Beta0.45
RSI64.46
Earnings DateApr 23, 2026

About SHE:300006

Chongqing Lummy Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It provides anti-tumor, anti-inflammatory, antibacterial, digestive, anti-virus, blood system, cardiovascular system, acid-base balance nutritional medicine, endocrine system drugs, tumor adjuvant medication, antifungal, and opioid receptor antagonists. The company was founded in 1999 and is headquartered in Chongqing, China. [Read more]

Sector Healthcare
Founded 1999
Employees 973
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300006
Full Company Profile

Financial Performance

In 2025, SHE:300006's revenue was 775.69 million, a decrease of -2.50% compared to the previous year's 795.60 million. Losses were -134.71 million, 53.4% more than in 2024.

Financial Statements